235 related articles for article (PubMed ID: 26817861)
1. Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.
Thurnherr T; Mah WC; Lei Z; Jin Y; Rozen SG; Lee CG
Sci Rep; 2016 Jan; 6():20065. PubMed ID: 26817861
[TBL] [Abstract][Full Text] [Related]
2. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
3. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
[TBL] [Abstract][Full Text] [Related]
4. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
[TBL] [Abstract][Full Text] [Related]
5. Screening key miRNAs for human hepatocellular carcinoma based on miRNA-mRNA functional synergistic network.
Zhang CJ; Du HJ
Neoplasma; 2017; 64(6):816-823. PubMed ID: 28895405
[TBL] [Abstract][Full Text] [Related]
6. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
Lu M; Kong X; Wang H; Huang G; Ye C; He Z
Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of differentially expressed mRNAs and miRNAs between hepatocellular carcinoma and their matched adjacent normal liver tissues.
Gao B; Ning S; Li J; Liu H; Wei W; Wu F; Tang Y; Feng Y; Li K; Zhang L
Oncol Rep; 2015 Jul; 34(1):325-33. PubMed ID: 26062888
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.
Huang DP; Zeng YH; Yuan WQ; Huang XF; Chen SQ; Wang MY; Qiu YJ; Tong GD
Int J Med Sci; 2021; 18(2):335-346. PubMed ID: 33390802
[No Abstract] [Full Text] [Related]
9. Bioinformatics analysis of tumor-educated platelet microRNAs in patients with hepatocellular carcinoma.
Zhu B; Gu S; Wu X; He W; Zhou H
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34806748
[TBL] [Abstract][Full Text] [Related]
10. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.
Han ZB; Zhong L; Teng MJ; Fan JW; Tang HM; Wu JY; Chen HY; Wang ZW; Qiu GQ; Peng ZH
Mol Oncol; 2012 Aug; 6(4):445-57. PubMed ID: 22552153
[TBL] [Abstract][Full Text] [Related]
11. Molecule mechanisms of Ganoderma lucidum treated hepatocellular carcinoma based on the transcriptional profiles and miRNA-target network.
Tang C; Zhao R; Ni H; Zhao K; He Y; Fang S; Chen Q
Biomed Pharmacother; 2020 May; 125():110028. PubMed ID: 32106374
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR‑136‑5p in hepatocellular carcinoma and its clinicopathological significance.
Ding H; Ye ZH; Wen DY; Huang XL; Zeng CM; Mo J; Jiang YQ; Li JJ; Cai XY; Yang H; Chen G
Mol Med Rep; 2017 Oct; 16(4):5393-5405. PubMed ID: 28849100
[TBL] [Abstract][Full Text] [Related]
13. miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.
Chen M; Hu W; Xiong CL; Qu Z; Yin CQ; Wang YH; Luo CL; Guan Q; Yuan CH; Wang FB
Oncotarget; 2016 Dec; 7(49):80751-80764. PubMed ID: 27811373
[TBL] [Abstract][Full Text] [Related]
14. Identification of miRNA and mRNA expression profiles by PCR microarray in hepatitis B virus‑associated hepatocellular carcinoma.
Cui XW; Qian ZL; Li C; Cui SC
Mol Med Rep; 2018 Dec; 18(6):5123-5132. PubMed ID: 30272372
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
16. RNA sequencing reveals the long noncoding RNA and mRNA profiles and identifies long non-coding RNA TSPAN12 as a potential microvascular invasion-related biomarker in hepatocellular carcinoma.
Lu J; Li B; Xiong X; Cheng N
Biomed Pharmacother; 2020 Jun; 126():110111. PubMed ID: 32222644
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential transcription factors, long noncoding RNAs, and microRNAs associated with hepatocellular carcinoma.
Yan H; Wang Q; Shen Q; Li Z; Tian J; Jiang Q; Gao L
J Cancer Res Ther; 2018 Sep; 14(Supplement):S622-S627. PubMed ID: 30249878
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma.
Liu Z; Wang Y; Dou C; Sun L; Li Q; Wang L; Xu Q; Yang W; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Mar; 37(1):49. PubMed ID: 29510736
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the miRNA and mRNA Coexpression Network and Their Prognostic Value in Hepatocellular Carcinoma.
Zhang H; Chen X; Yuan Y
Biomed Res Int; 2020; 2020():8726567. PubMed ID: 33274225
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma.
Wang G; Dong F; Xu Z; Sharma S; Hu X; Chen D; Zhang L; Zhang J; Dong Q
BMC Cancer; 2017 Dec; 17(1):805. PubMed ID: 29191172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]